7th World Congress on "Alternatives and Animal Use''

Monday,31 August 2009 - Tuesday,01 September 2009
  • Country :Belgium

 

INFORMATION EVENT* ON FP7 CALL ON THE HEALTH TOPIC "TOWARDS THE REPLACEMENT OF REPEATED DOSE SYSTEMIC TOXICITY TESTING IN HUMAN SAFETY ASSESSMENT"


in Rome
on
31 August and 1 September 2009

*Organised by the European Commission and The European Cosmetics Association

The Information Event is linked to the 7th World Congress on "Alternatives and Animal Use in Life Sciences"
Location:

ROME CAVALIERI HOTEL
Via A. Cadlolo, 101 - 00135 - Rome (Italy)
Tel. +39 06 35091 - website: www.romecavalieri.com

 

Agenda:

August 31, 2009

1st Session: General Information on the Call for Proposals

18h30 - 18h40               

Welcome Address, Prof. Thomas Hartung

18h40 – 19h00

A new strategy in alternative testing

Ruxandra Draghia-Akli, Director, European Commission DG RTD.F, Brussels

19h00 – 19h20

Colipa's Commitment in Funding Research in the Replacement of Animal Tests

Bertil Heerink, Director-General, Colipa, Brussels

19h20 – 19h40

Towards the scientific strategy for the replacement of animals in repeated dose systemic toxicity testing

Horst Spielmann, Director a.D., BfR, Berlin

19h40 – 20h00

Questions and Answers

20h00

Announcement of 2nd session (on 1st of September) by Thomas Hartung

September 1, 2009

2nd Session: Specific technical and administrative information and discussion on the Call for Proposals

Alternative Testing Strategies
Call for proposals on ''Towards the replacement of repeated dose systemic toxicity testing in human safety assessment"
Bringing together interested scientists


(Please note that no attendance fee is required for this event)

Background
The European Commission has launched on 30 July 2009 a Call for Proposals for research projects in the field of 'alternative testing' in order to develop a strategy towards the replacement of repeated dose systemic toxicity testing in human safety assessment. The contents of the call  (six research topics and one coordinating action) is based on recommendations made by a group of experts jointly selected by the European Commission and by Colipa.
Besides the normal FP7 rules a number of conditions has been set as regards the projects to be selected for funding. It is essential to carefully read the respective Call Fiche and the work programme published on the CORDIS website. Special attention should be paid to the funding ranges for the individual topics as they are considered eligibility criteria.
For projects selected in this specific call 50% of the total eligible cost will be paid by the European Commission independent from the funding schemes, the activities and type of organisations involved. Participants are encouraged to seek for complementary funding from third parties, e.g. industry. At the latest at this point interested scientists are invited to visit the web site of Colipa (www.colipa.eu).     
Some further funding conditions and guiding remarks:

  • Applicants are strongly encouraged to examine how new scientific disciplines could be included in the project proposals in order to develop truly novel approaches towards human safety assessment.
  • The number and type of project partners will be defined by the research tasks to be carried out.
  • Only proposals not involving tests on living animals are eligible for funding.
  • Research work concerning the effects of nanoparticles is excluded from the present call.
  • The six research topics are considered to work together in form of a cluster. Therefore, in each proposals the foreseen links and interactions with the other topics should be described.
  • The partners in all research projects selected for funding should agree to an integrated data analysis concept (see 4.2.9.6).
  • The organisation of annual cluster meetings, the corresponding progress reporting, the identification of gaps in knowledge and technologies and the definition of the respective RTD priorities will be organised by the coordinating project/action. The necessary interaction modalities between the six research projects and the coordinating project will be included in the technical annexes of all projects involved.

18.30 - 18.40
Technical Introduction, J. Büsing, European Commission, DG RTD
18.40 – 18.50 Repeated dose systemic toxicity testing, Christof Burek, University of Würzburg, Germany
18.50 – 19.00 Scientific introduction to the research cluster, Vera Rogiers, VUB, Brussels, Belgium
19.00 – 19.40 Moderated round table discussions/topic; open questions
19.40 – 20.00 Plenary session: Questions/answers; next steps, moderated by Gerald Renner, Director Science and Research, Colipa

Open discussions among participants

Additional information:
The coordinators of ongoing RTD projects met on 30 July 2009 in Portugal in order to analyse progress made in the individual projects and to identify which issues of the new call are partly addressed by ongoing projects. This information is important for those who intend to set up new projects in order to avoid duplication with ongoing work. A "matrix" between the new topics and ongoing projects has been established and is attached to this agenda. More detailed information about ongoing projects and the partners involved can be found in the book "Alternative Testing Strategies -  Progress report 2009", downloadable under:
ftp://ftp.cordis.europa.eu/pub/fp7/docs/alternative-testing-progress-report-2009_en.pdf

***
Scientists interested in applying to the "FP7 – Health-2010 – Alternative Testing Strategies" (Towards the replacement of repeated dose systemic toxicity testing in human safety assessment) are kindly invited to discuss details of the call and to present their specific interest in the individual topics of the call. The session should offer opportunities to get into contact with other scientists interested in setting up proposals for research projects.
It is planned to organise this session in plenary and 'break out' discussions.

 

[Back]